Joshua Baker

Apr 12, 2023 | ard.bmj.com | Joshua Baker |Bryant R England |Ted R Mikuls

arthritis rheumatoid inflammation cytokines We were pleased to read the commentary on our recent article by Ruscitti et al and we share their interest in the potential role of inflammatory pathways in the development of metabolic disorders such as diabetes in patients with rheumatoid arthritis (RA).1 Indeed, both interleukin (IL)-1 and IL-6 levels were independently associated with the development of diabetes in our original study, implicating them as potential mediators of metabolic changes...